2221-00-3

Basic information

• Product Name: 4-(1H-Imidazol-1-yl)aniline
• Synonyms: ART-CHEM-BB B021935;1-(4-AMINOPHENYL)IMIDAZOLE;1-(4'-AMINOPHEN-1-YL)IMIDAZOLE;1-(4-AMINOPHENYL)-1H-IMIDAZOLE;4-(IMIDAZOL-1-YL)-ANILINE;4-IMIDAZOL-1-YL-PHENYLAMINE;4-(1H-IMIDAZOL-1-YL)ANILINE;AKOS B021935
• CAS NO: 2221-00-3
• Molecular Formula: C₉H₉N₃
• Molecular Weight: 159.19
• Product Categories: pharmacetical;Imidazol&Benzimidazole;Heterocyclic Compounds;Amines;Phenyls & Phenyl-Het
• Mol File: 2221-00-3.mol
• Article Data: 65

Chemical Properties

• Melting Point: 143-147 °C(lit.)
• Boiling Point: 355.4 °C at 760 mmHg
• Flash Point: 168.7 °C
• Appearance: /
• Density: 1.2 g/cm³
• Vapor Pressure: 3.15E-05mmHg at 25°C
• Refractive Index: 1.641
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 6.05±0.10(Predicted)
• CAS DataBase Reference: 4-(1H-Imidazol-1-yl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1H-Imidazol-1-yl)aniline(2221-00-3)
• EPA Substance Registry System: 4-(1H-Imidazol-1-yl)aniline(2221-00-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 2221-00-3(Hazardous Substances Data)

Usage

Chemical Properties

White powder

InChI:InChI=1/C9H9N3/c10-8-1-3-9(4-2-8)12-6-5-11-7-12/h1-7H,10H2

Upstream product

• 636-98-6 p-nitrobenzene iodide 
• 100-00-5 4-chlorobenzonitrile 
• 51581-54-5 1-(4-chlorophenyl)imidazole 
• 2301-25-9 1-(4-nitrophenyl)-1H-imidazole 
• 7772-99-8 stannous chloride 
• 350-46-9 4-Fluoronitrobenzene 
• 288-32-4 1H-imidazole 
• 106-40-1 4-bromo-aniline 
• 540-37-4 p-aminoiodobenzene 

Downstream Products

• 453563-19-4 (2-chloro-(3-pyridyl))-N-(4-imidazolyl-phenyl)-carboxamide 
• 223785-60-2 1-(4-isothiocyanatophenyl)-1H-imidazole 
• 181869-34-1 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-imidazolyl)phenyl]-2(1H,3H)-imidazolone 
• 325989-25-1 1-(2,2-diethoxy-ethyl)-3-(4-imidazol-1-yl-phenyl)-urea 
• 325989-18-2 C₁₀H₁₁N₅O 
• 181870-52-0 1-[4-(1H-1-imidazolyl)phenyl]-2(1H,3H)-imidazolone 

Relevant articles and documents

Axial Ligand Coordination Tuning of the Electrocatalytic Activity of Iron Porphyrin Electrografted onto Carbon Nanotubes for the Oxygen Reduction Reaction

The oxygen reduction reaction (ORR) is essential in many life processes and energy conversion systems. It is desirable to design transition metal molecular catalysts inspired by enzymatic oxygen activation/reduction processes as an alternative to noble-metal-Pt-based ORR electrocatalysts, especially in view point of fuel cell commercialization. We have fabricated bio-inspired molecular catalysts electrografted onto multiwalled carbon nanotubes (MWCNTs) in which 5,10,15,20-tetra(pentafluorophenyl) iron porphyrin (iron porphyrin FeF20TPP) is coordinated with covalently electrografted axial ligands varying from thiophene to imidazole on the MWCNTs’ surface. The catalysts’ electrocatalytic activity varied with the axial coordination environment (i. e., S-thiophene, N-imidazole, and O-carboxylate); the imidazole-coordinated catalyst MWCNTs-Im-FeF20TPP exhibited the highest ORR activity among the prepared catalysts. When MWCNT-Im-FeF20TPP was loaded onto the cathode of a zinc?air battery, an open-cell voltage (OCV) of 1.35 V and a maximum power density (Pmax) of 110 mW cm?2 were achieved; this was higher than those of MWCNTs-Thi-FeF20TPP (OCV=1.30 V, Pmax=100 mW cm?2) and MWCNTs-Ox-FeF20TPP (OCV=1.28 V, Pmax=86 mW cm?2) and comparable with a commercial Pt/C catalyst (OCV=1.45 V, Pmax=120 mW cm?2) under similar experimental conditions. This study provides a time-saving method to prepare covalently immobilized molecular electrocatalysts on carbon-based materials with structure–performance correlation that is also applicable to the design of other electrografted catalysts for energy conversion.

2-pyridine substituted urea structural small molecule compounds as well as synthesis and application thereof

The invention relates to 2-pyridine substituted urea structural small molecule compounds as well as synthesis and application thereof. Specifically, the invention discloses the compounds represented by a formula (I) shown in the specification, enantiomers, diastereomers, racemates or a mixture of the compounds, or a pharmaceutically acceptable salt, hydrate and solvate of the compounds, a preparation method of the above materials, and applications of the above materials in preparation of an ASK1 small molecule inhibitor, or medicines for preventing and/or treating diseases related to ASK1, especially liver diseases, lung diseases, cardiovascular diseases, kidney diseases and metabolic diseases.

Schiff base fluorescent compound and synthesis method thereof, and method for fluorescently detecting zinc ions

The invention discloses a Schiff base fluorescent compound and a synthesis method thereof, and a method for fluorescently detecting zinc ions. The Schiff base fluorescent compound is as shown in the specification. The synthesis method for the Schiff base